CytomX Therapeutics (CTMX) Interest Coverage Ratio (QoQ) (2014 - 2025)
CytomX Therapeutics (CTMX) Interest Coverage Ratio (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63.99% |
| Sep 30, 2025 | -1,150.65% |
| Jun 30, 2025 | -105.68% |
| Mar 31, 2025 | -42.30% |
| Dec 31, 2024 | 666.60% |
| Sep 30, 2024 | 147.45% |
| Jun 30, 2024 | -170.69% |
| Mar 31, 2024 | 86,639.19% |
| Dec 31, 2023 | -100.31% |
| Dec 31, 2022 | 88.94% |
| Sep 30, 2022 | -44.49% |
| Jun 30, 2022 | 25.87% |
| Mar 31, 2022 | -30.84% |
| Dec 31, 2021 | -9.36% |
| Sep 30, 2021 | -408.88% |
| Jun 30, 2021 | 73.93% |
| Mar 31, 2021 | 2.80% |
| Dec 31, 2020 | 7.08% |
| Sep 30, 2020 | 2.10% |
| Jun 30, 2020 | -369.09% |